AstraZeneca pauses coronavirus vaccine trial, rollout doubts dent shares
- Japan's Nikkei posts biggest point gain for fiscal year
- Citi downgrades tech stocks as its flagship indicator signals 'euphoria' levels
- UBS sees 5 warnings signals on semiconductor chip stocks
- 2 reasons why Tesla stock fell on Thursday
- US consumer sentiment tops estimates in March to hit nearly 3-yr high, UMich says
- AMC Entertainment (AMC) enters into an equity distribution agreement
- Kerrisdale Capital is short Microstrategy (MSTR), long bitcoin
- AMC Entertainment (AMC) Enters $250M ATM Agreement
- Intuitive Machines (LUNR) Files for $300M Share Offering, 160M Share Offering by Selling Stockholders
- Home Depot (HD) to Acquire SRS Distribution for $18.25B EV
STAT Confirms Earlier Reports AstraZeneca (AZN) Vaccine Patent Had Transverse Myelitis, Could be Discharged Today
September 9, 2020 12:00 PM EDTSTAT Confirms Earlier Reports AstraZeneca (NYSE: AZN) Vaccine Patent Had Transverse Myelitis, Could be Discharged Today
... More